(Reuters) – Danish drugmaker Novo Nordisk (NYSE:) has mitigation plans to reduce or prevent any interruptions in its production due to U.S. seaport strikes, CNBC reported on Tuesday, citing a company spokesperson.
The report added that the famous pharmaceutical manufacturers, Wegovy and Ozempic, are planning to ship their products to and from the United States via air freight.
Novo did not immediately respond to Reuters’ request for comment.
The company imports some of its active pharmaceutical ingredient, or semaglutide, into the United States for the blockbuster diabetes drug Ozempic and weight loss treatment Wegovy, according to the report.
The US Department of Health and Human Services (HHS) said earlier on Tuesday that its preliminary analysis showed that a strike by dockworkers on the US East Coast and Gulf Coast should have a limited impact on the availability of essential goods such as drugs and medical devices.
Dockworkers have launched their first large-scale strike in nearly 50 years, halting about half of the country’s shipping after negotiations for a new labor contract collapsed over wages.